Khalafallah, Alhossain A., Bernadene Fernandopulle, and Terry Brain. 2010. “Dose-Modified Lenalidomide Induces Sustained Hematological Response in Patients With Intermediate to High Risk Myelodysplasia”. Mediterranean Journal of Hematology and Infectious Diseases 2 (2):e2010012. https://doi.org/10.4084/mjhid.2010.012.